BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38431799)

  • 1. Improving access to exome sequencing in a medically underserved population through the Texome Project.
    Vuocolo B; German RJ; Lalani SR; Murali CN; Bacino CA; Baskin S; Littlejohn R; Odom JD; McLean S; Schmid C; Nutter M; Stuebben M; Magness E; Juarez O; El Achi D; Mitchell B; Glinton KE; Robak L; Nagamani SCS; Saba L; Ritenour A; Zhang L; Streff H; Chan K; Kemere KJ; Carter K; ; Owen N; Vossaert L; Liu P; Bellen H; Wangler MF
    Genet Med; 2024 Jun; 26(6):101102. PubMed ID: 38431799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial.
    Staley BS; Milko LV; Waltz M; Griesemer I; Mollison L; Grant TL; Farnan L; Roche M; Navas A; Lightfoot A; Foreman AKM; O'Daniel JM; O'Neill SC; Lin FC; Roman TS; Brandt A; Powell BC; Rini C; Berg JS; Bensen JT
    Trials; 2021 Jun; 22(1):395. PubMed ID: 34127041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel hemizygous single-nucleotide duplication in RPGR in a patient with retinal dystrophy and sensorineural hearing loss.
    German RJ; Vuocolo B; Vossaert L; Owen N; Lewis RA; Saba L; ; Wangler MF; Nagamani S
    Mol Genet Genomic Med; 2024 Feb; 12(2):e2404. PubMed ID: 38404254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS).
    Trosman JR; Weldon CB; Slavotinek A; Norton ME; Douglas MP; Phillips KA
    Genet Med; 2020 Feb; 22(2):283-291. PubMed ID: 31501586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Answers for Kids: Toward more equitable access to genomic testing for rare diseases in rural populations.
    Cohen ASA; Berrios CD; Zion TN; Barrett CM; Moore R; Boillat E; Belden B; Farrow EG; Thiffault I; Zuccarelli BD; Pastinen T
    Am J Hum Genet; 2024 May; 111(5):825-832. PubMed ID: 38636509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision therapy for a medically actionable ATP1A3 variant from a genomic medicine program in an underserved population.
    Ford CP; Littlejohn RO; German R; Vuocolo B; Aceves J; Vossaert L; Owen N; Wangler M; Schmid CA;
    Mol Genet Genomic Med; 2023 Dec; 11(12):e2272. PubMed ID: 37614148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding access to genomics in an ethnically diverse south Florida population: A comparison of demographics in odyssey and rapid whole genome sequencing programs.
    Hussain SB; Quittner AL; Brown M; Li-Rosi AM
    J Genet Couns; 2020 Aug; 29(4):553-561. PubMed ID: 32277851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis.
    Pucel J; Briere LC; Reuter C; Gochyyev P; ; LeBlanc K
    Genet Med; 2024 Jun; 26(6):101115. PubMed ID: 38436216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study.
    Shickh S; Gutierrez Salazar M; Zakoor KR; Lázaro C; Gu J; Goltz J; Kleinman D; Noor A; Khalouei S; Mighton C; Reble E; Kodida R; Bombard Y; DiTroia S; Baxter S; Watkins N; Care M; Adler A; Horsburgh S; Morar O; Murphy J; Nevay DL; Szybowska M; Aronson M; Panchal S; Godoy R; Holter S; Randall Armel S; Semotiuk K; Elser C; Kim RH; Chitayat D; So J; Faghfoury H; Silver J; Morel CF; Lerner-Ellis J
    J Med Genet; 2021 Apr; 58(4):275-283. PubMed ID: 32581083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genomic landscape of rare disorders in the Middle East.
    El Naofal M; Ramaswamy S; Alsarhan A; Nugud A; Sarfraz F; Janbaz H; Taylor A; Jain R; Halabi N; Yaslam S; Alfalasi R; Shenbagam S; Rabea F; Bitzan M; Yavuz L; Wafadari D; Abulhoul H; Shankar S; Al Maazmi M; Rizk R; Alloub Z; Elbashir H; Babiker MOE; Chencheri N; AlBanna A; Sultan M; El Bitar M; Kherani S; Thalange N; Alshryda S; Di Donato R; Tzivinikos C; Majid I; Freeman AF; Gonzalez C; Khan AO; Hamdan H; Abuhammour W; AlAwadhi M; AlKhayat A; Alsheikh-Ali A; Abou Tayoun AN
    Genome Med; 2023 Jan; 15(1):5. PubMed ID: 36703223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of Whole Exome Sequencing for Diagnostic Odyssey Cases of an Individualized Medicine Clinic: The Mayo Clinic Experience.
    Lazaridis KN; Schahl KA; Cousin MA; Babovic-Vuksanovic D; Riegert-Johnson DL; Gavrilova RH; McAllister TM; Lindor NM; Abraham RS; Ackerman MJ; Pichurin PN; Deyle DR; Gavrilov DK; Hand JL; Klee EW; Stephens MC; Wick MJ; Atkinson EJ; Linden DR; Ferber MJ; Wieben ED; Farrugia G;
    Mayo Clin Proc; 2016 Mar; 91(3):297-307. PubMed ID: 26944241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-first evaluation with exome sequence and clinical data uncovers underdiagnosed genetic disorders in a large healthcare system.
    Forrest IS; Duffy Á; Park JK; Vy HMT; Pasquale LR; Nadkarni GN; Cho JH; Do R
    Cell Rep Med; 2024 May; 5(5):101518. PubMed ID: 38642551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective review of multiple findings in diagnostic exome sequencing: half are distinct and half are overlapping diagnoses.
    Smith ED; Blanco K; Sajan SA; Hunter JM; Shinde DN; Wayburn B; Rossi M; Huang J; Stevens CA; Muss C; Alcaraz W; Hagman KDF; Tang S; Radtke K
    Genet Med; 2019 Oct; 21(10):2199-2207. PubMed ID: 30894705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing.
    Reuter CM; Kohler JN; Bonner D; Zastrow D; Fernandez L; Dries A; Marwaha S; Davidson J; Brokamp E; Herzog M; Hong J; Macnamara E; Rosenfeld JA; Schoch K; Spillmann R; ; Loscalzo J; Krier J; Stoler J; Sweetser D; Palmer CGS; Phillips JA; Shashi V; Adams DA; Yang Y; Ashley EA; Fisher PG; Mulvihill JJ; Bernstein JA; Wheeler MT
    J Genet Couns; 2019 Dec; 28(6):1107-1118. PubMed ID: 31478310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive iterative approach is highly effective in diagnosing individuals who are exome negative.
    Shashi V; Schoch K; Spillmann R; Cope H; Tan QK; Walley N; Pena L; McConkie-Rosell A; Jiang YH; Stong N; Need AC; Goldstein DB;
    Genet Med; 2019 Jan; 21(1):161-172. PubMed ID: 29907797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implementation of an enhanced clinical model to improve the diagnostic yield of exome sequencing for patients with a rare genetic disease: A Canadian experience.
    Ediae GU; Lemire G; Chisholm C; Hartley T; Eaton A; Osmond M; Rojas SK; Huang L; Gillespie M; ; Sawyer SL; Boycott KM
    Am J Med Genet A; 2023 Feb; 191(2):338-347. PubMed ID: 36331261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of exome sequencing in detecting rare and undiagnosed diseases.
    Burdick KJ; Cogan JD; Rives LC; Robertson AK; Koziura ME; Brokamp E; Duncan L; Hannig V; Pfotenhauer J; Vanzo R; Paul MS; Bican A; Morgan T; Duis J; Newman JH; Hamid R; Phillips JA;
    Am J Med Genet A; 2020 Jun; 182(6):1400-1406. PubMed ID: 32190976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-Sectional Analysis of Exome Sequencing Diagnosis in Patients With Neurologic Phenotypes Facing Barriers to Clinical Testing.
    Watson S; Ngo KJ; Stevens HA; Wong DY; Kim J; Song Y; Han B; Hyun SI; Khang R; Ryu SW; Lee E; Seo G; Lee H; Lajonchere C; Fogel BL
    Neurol Genet; 2024 Jun; 10(3):e200133. PubMed ID: 38617022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of integrated translational research on clinical exome sequencing.
    Klee EW; Cousin MA; Pinto E Vairo F; Morales-Rosado JA; Macke EL; Jenkinson WG; Ferrer A; Schultz-Rogers LE; Olson RJ; Oliver GR; Sigafoos AN; Schwab TL; Zimmermann MT; Urrutia RA; Kaiwar C; Gupta A; Blackburn PR; Boczek NJ; Prochnow CA; Lowy RJ; Mulvihill LA; McAllister TM; Aoudia SL; Kruisselbrink TM; Gunderson LB; Kemppainen JL; Fisher LJ; Tarnowski JM; Hager MM; Kroc SA; Bertsch NL; Agre KE; Jackson JL; Macklin-Mantia SK; Murphree MI; Rust LM; Summer Bolster JM; Beck SA; Atwal PS; Ellingson MS; Barnett SS; Rasmussen KJ; Lahner CA; Niu Z; Hasadsri L; Ferber MJ; Marcou CA; Clark KJ; Pichurin PN; Deyle DR; Morava-Kozicz E; Gavrilova RH; Dhamija R; Wierenga KJ; Lanpher BC; Babovic-Vuksanovic D; Farrugia G; Schimmenti LA; Stewart AK; Lazaridis KN
    Genet Med; 2021 Mar; 23(3):498-507. PubMed ID: 33144682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service.
    Hill M; Ellard S; Fisher J; Fulop N; Knight M; Kroese M; Ledger J; Leeson-Beevers K; McEwan A; McMullan D; Mellis R; Morris S; Parker M; Tapon D; Baple E; Blackburn L; Choudry A; Lafarge C; McInnes-Dean H; Peter M; Ramakrishnan R; Roberts L; Searle B; Smith E; Walton H; Wynn SL; Han Wu W; Chitty LS
    NIHR Open Res; 2022; 2():10. PubMed ID: 35935673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.